Astal Laboratories Ltd

BSE :512600 NSE :- Sector : Pharmac..
83.98
Change: 1.46(1.77%)
Buy Sell SIP
52 week Low
66.72
52 week High
118.65
Day low
82.10
Day high
84
Prev Close
82.52
Open
82.10
6M return
9.55%
1Y return
-26.62%
MCap(Rs. in Cr.)
145.56
Total Volume
8,673
Face Value : 10
Listed Since
PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
15.60
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
5.29
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
3.70
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
86.31%
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)
0.00

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales
1,772.59%

Sales Industry Avg
46.26%

PAT
44,550.00%

PAT Industry Avg
122.75%

Jun 2025
( in Cr.)		Mar 2025
( in Cr.)		Dec 2024
( in Cr.)		Sep 2024
( in Cr.)		FY 2025
( in Cr.)
Sales25.3323.4714.4613.1664.23
Gross Profit2.913.953.102.8012.20
Operating Profit00000
Profit Before Tax2.553.852.922.7711.98
Tax0.461.110.430.773.05
Profit After Tax2.092.742.4928.93
No data available
No data available


Relative to Sensex rtn in 3 year
386.34%

Relative to Nifty rtn in 3 year
341.71%



1 Year (%)2 Year (%)3 Year (%)
Astal Lab-27162193
Bse Sensex-02240
Nifty 50-02644

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

Astal Lab
83.98
Change: 1.46 (1.77%)
1 Year return
-26.62%
Risk (Std Dev)
0.07%
PE Ratio
15.60
MCap( in Cr.)
145.56
BUY SELL
Fermenta Biotec.
338.40
Change: -4.10 (-1.20%)
1 Year return
13.88%
Risk (Std Dev)
0.17%
PE Ratio
9.64517
MCap( in Cr.)
1,008.01
BUY SELL
Bharat Parenter.
1,319.00
Change: -0.95 (-0.07%)
1 Year return
-20.65%
Risk (Std Dev)
0.21%
PE Ratio
NM
MCap( in Cr.)
909.70
BUY SELL
Jenburkt Pharma
1,107.55
Change: -14.40 (-1.28%)
1 Year return
-2.34%
Risk (Std Dev)
0.14%
PE Ratio
15.26
MCap( in Cr.)
495.15
BUY SELL
Zenotech Lab.
52.32
Change: -0.59 (-1.12%)
1 Year return
-45.43%
Risk (Std Dev)
0.13%
PE Ratio
77.81
MCap( in Cr.)
322.91
BUY SELL
View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth 73,377.00 with a Loss of -26.62%

News

Stay tuned to the latest developments and happenings in the company.

Astal Laboratories to convene AGM

Astal Laboratories announced that the 32th Annual General Meeting(AGM) of the company will be held on 12 September 2025.Powered by Capit....

19 Aug 2025 09:54

Astal Laboratories standalone net profit rises 23.67% in the June 2025 quarter

Net profit of Astal Laboratories rose 23.67% to Rs 2.09 crore in the quarter ended June 2025 as against Rs 1.69 crore during the previous quarter ende....

13 Aug 2025 12:29

Astal Laboratories to discuss results

Astal Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 2025.Powered by Capital Market - Live News<....

07 Aug 2025 14:43

Astal Laboratories standalone net profit rises 389.29% in the March 2025 quarter

Net profit of Astal Laboratories rose 389.29% to Rs 2.74 crore in the quarter ended March 2025 as against Rs 0.56 crore during the previous quarter en....

20 May 2025 07:45

Astal Laboratories to declare Quarterly Results

Astal Laboratories will hold a meeting of the Board of Directors of the Company on 19 May 2025.Powered by Capital Market - Live News....

14 May 2025 15:16

Astal Laboratories standalone net profit rises 408.16% in the December 2024 quarter

Net profit of Astal Laboratories rose 408.16% to Rs 2.49 crore in the quarter ended December 2024 as against Rs 0.49 crore during the previous quarter....

28 Jan 2025 07:30

View More
Subscribe for our
newsletter
Open Account Now